Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-May-24 5:16 PM View:  | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 03-May-24 | Sale | 4,674 | $14.03 | $65,576.20 | (< 1%) 3.41M to 3.41M | |
| 03-May-24 5:16 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 02-May-24 | Sale | 8,842 | $14.01 | $123,876.00 | (< 1%) 3.42M to 3.41M | |
| 03-May-24 5:16 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 01-May-24 | Sale | 15,690 | $14.02 | $219,974.00 | (< 1%) 3.44M to 3.42M | |
| 26-Apr-24 5:01 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 24-Apr-24 | Sale | 1,781 | $14.06 | $25,040.90 | (< 1%) 3.44M to 3.44M | |
| 23-Apr-24 6:38 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 23-Apr-24 | Sale | 21,791 | $14.29 | $311,393.00 | (< 1%) 3.46M to 3.44M | |
| 23-Apr-24 6:38 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 22-Apr-24 | Sale | 24,609 | $14.05 | $345,756.00 | (< 1%) 3.48M to 3.46M | |
| 23-Apr-24 6:38 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 19-Apr-24 | Sale | 18,253 | $14.02 | $255,907.00 | (< 1%) 3.5M to 3.48M | |
| 18-Apr-24 5:10 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 18-Apr-24 | Sale | 2,623 | $14.06 | $36,879.40 | (< 1%) 3.5M to 3.5M | |
| 18-Apr-24 5:10 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 17-Apr-24 | Sale | 300 | $14.15 | $4,245.00 | (< 1%) 3.5M to 3.5M | |
| 18-Apr-24 5:10 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 16-Apr-24 | Sale | 14,069 | $14.01 | $197,107.00 | (< 1%) 3.52M to 3.5M | |
| 15-Apr-24 5:25 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 12-Apr-24 | Sale | 23,101 | $14.42 | $333,116.00 | (< 1%) 3.54M to 3.52M | |
| 15-Apr-24 5:25 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 11-Apr-24 | Sale | 461,899 | $14.49 | $6,692,920.00 | (12%) 4.0M to 3.54M | |
| 28-Feb-24 8:56 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 27-Feb-24 | Grant | 12,500 | -- | -- | 16% 77.76K to 90.26K | |
| 28-Feb-24 8:54 PM View: | Kuhn Rebecca Chief Financial Officer | Neuropace Inc (NPCE) | 27-Feb-24 | Grant | 12,500 | -- | -- | 9% 139.7K to 152.2K | |
| 28-Feb-24 8:52 PM View: | Becker Joel Chief Executive Officer Director | Neuropace Inc (NPCE) | 27-Feb-24 | Grant | 52,470 | -- | -- | 100% 0 to 52.47K | |
| 06-Feb-24 7:16 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 05-Feb-24 | Sale (Planned) | 3,446 | $15.17 | $52,278.20 | (4%) 81.21K to 77.76K | |
| 06-Feb-24 7:16 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 02-Feb-24 | Sale (Planned) | 14,143 | $15.07 | $213,122.00 | (15%) 95.35K to 81.21K | |
| 01-Feb-24 9:47 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 01-Feb-24 | Sale (Planned) | 663 | $15.04 | $9,971.06 | (< 1%) 96.01K to 95.35K | |
| 01-Feb-24 9:47 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 31-Jan-24 | Sale (Planned) | 1,923 | $15.08 | $28,989.60 | (2%) 97.94K to 96.01K | |
| 01-Feb-24 9:47 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 30-Jan-24 | Sale (Planned) | 11,262 | $15.10 | $170,004.00 | (10%) 109.2K to 97.94K | |
| 26-Jan-24 6:04 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 25-Jan-24 | Sale (Planned) | 1 | $15.00 | $15.00 | (< 1%) 109.2K to 109.2K | |
| 26-Jan-24 6:04 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 24-Jan-24 | Sale (Planned) | 827 | $15.02 | $12,425.70 | (< 1%) 110.03K to 109.2K | |
| 28-Dec-23 5:47 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 27-Dec-23 | Sale (Planned) | 13,300 | $10.12 | $134,648.00 | (11%) 123.33K to 110.03K | |
| 28-Dec-23 5:47 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 26-Dec-23 | Sale (Planned) | 102 | $10.00 | $1,020.00 | (< 1%) 123.43K to 123.33K | |
| 22-Dec-23 4:21 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 20-Dec-23 | Sale (Planned) | 2,730 | $10.14 | $27,695.30 | (2%) 126.16K to 123.43K | |
| 07-Dec-23 4:07 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 06-Dec-23 | Sale (Planned) | 11,005 | $8.16 | $89,773.30 | (8%) 137.16K to 126.16K | |
| 01-Dec-23 9:57 PM View: | Kck Ltd. 10% Owner | Neuropace Inc (NPCE) | 01-Dec-23 | Sale | 3,241 | $8.73 | $28,293.90 | (< 1%) 5.6M to 5.59M | |
| 01-Dec-23 9:57 PM View: | Kck Ltd. 10% Owner | Neuropace Inc (NPCE) | 30-Nov-23 | Sale | 7,282 | $8.84 | $64,372.90 | (< 1%) 5.6M to 5.6M | |
| 01-Dec-23 9:57 PM View: | Kck Ltd. 10% Owner | Neuropace Inc (NPCE) | 29-Nov-23 | Sale | 5,644 | $8.72 | $49,215.70 | (< 1%) 5.61M to 5.6M | |
| 29-Nov-23 5:35 PM View: | Kck Ltd. 10% Owner | Neuropace Inc (NPCE) | 28-Nov-23 | Sale | 4,681 | $8.75 | $40,958.80 | (< 1%) 5.61M to 5.61M | |
| 29-Nov-23 5:35 PM View: | Kck Ltd. 10% Owner | Neuropace Inc (NPCE) | 27-Nov-23 | Sale | 6,490 | $8.96 | $58,150.40 | (< 1%) 5.62M to 5.61M | |
| 04-Oct-23 5:36 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 03-Oct-23 | Sale | 700 | $9.02 | $6,314.00 | (< 1%) 4.0M to 4.0M | |
| 04-Oct-23 5:36 PM View: | Orbimed Advisors LLC 10% Owner | Neuropace Inc (NPCE) | 02-Oct-23 | Sale | 7,614 | $9.08 | $69,135.10 | (< 1%) 4.01M to 4.0M | |
| 22-Feb-23 7:38 PM View: | Favet Michael Chief Executive Officer Director | Neuropace Inc (NPCE) | 21-Feb-23 | Grant | 225,000 | -- | -- | 124% 182.08K to 407.08K | |
| 22-Feb-23 7:39 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 20-Feb-23 | Grant | 80,000 | -- | -- | 140% 57.16K to 137.16K | |
| 22-Feb-23 7:53 PM View: | Kuhn Rebecca Chief Financial Officer | Neuropace Inc (NPCE) | 20-Feb-23 | Grant | 80,000 | -- | -- | 134% 59.7K to 139.7K | |
| 22-Feb-23 7:54 PM View: | Ridley Irina Chief Legal Officer/Secretary | Neuropace Inc (NPCE) | 20-Feb-23 | Grant | 80,000 | -- | -- | 131% 61.14K to 141.14K | |
| 23-Nov-22 5:29 PM View: | Accelmed Partners II L.P. 10% Owner | Neuropace Inc (NPCE) | 22-Nov-22 | Purchase | 62,398 | $1.50 | $93,534.60 | < 1% 8.74M to 8.8M | |
| 23-Nov-22 5:29 PM View: | Accelmed Partners II L.P. 10% Owner | Neuropace Inc (NPCE) | 21-Nov-22 | Private Purchase | 327,893 | $1.50 | $491,512.00 | 4% 8.41M to 8.74M | |
| 02-Nov-22 9:18 PM View: | Kuhn Rebecca Chief Financial Officer | Neuropace Inc (NPCE) | 31-Oct-22 | Option Exercise | 1,428 | $0.03 | $37.13 | 2% 58.28K to 59.7K | |
| 20-Oct-22 7:57 PM View: | Lacob Joseph Director | Neuropace Inc (NPCE) | 18-Oct-22 | Option Exercise | 192 | $0.03 | $4.99 | < 1% 351.92K to 352.11K | |
| 11-Oct-22 4:09 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 07-Oct-22 | Option Exercise | 576 | $0.03 | $14.98 | 1% 56.59K to 57.16K | |
| 09-Jun-22 7:47 PM View: | Ridley Irina General Counsel and Secretary | Neuropace Inc (NPCE) | 08-Jun-22 | Sale (Planned) | 2,500 | $5.78 | $14,445.00 | (4%) 63.64K to 61.14K | |
| 08-Mar-22 4:43 PM View: | Favet Michael Chief Executive Officer Director | Neuropace Inc (NPCE) | 08-Mar-22 | Grant | 155,080 | -- | -- | 574% 27.0K to 182.08K | |
| 07-Mar-22 8:06 PM View: | Morrell Martha Chief Medical officer | Neuropace Inc (NPCE) | 03-Mar-22 | Grant | 46,760 | -- | -- | 476% 9.83K to 56.59K | |
| 07-Mar-22 8:06 PM View: | Kuhn Rebecca Chief Financial Officer | Neuropace Inc (NPCE) | 03-Mar-22 | Grant | 46,740 | -- | -- | 405% 11.54K to 58.28K | |
| 07-Mar-22 8:07 PM View: | Ridley Irina General Counsel and Secretary | Neuropace Inc (NPCE) | 03-Mar-22 | Grant | 56,987 | -- | -- | 857% 6.65K to 63.64K | |
| 01-Mar-22 7:35 PM View: | Ridley Irina General Counsel and Secretary | Neuropace Inc (NPCE) | 28-Feb-22 | Sale (Planned) | 1,470 | $7.54 | $11,081.70 | (18%) 8.12K to 6.65K | |
| 08-Jun-21 6:04 PM View: | Favet Michael Chief Executive Officer Director | Neuropace Inc (NPCE) | 04-Jun-21 | Grant | 26,590 | -- | -- | 116% 22.95K to 49.54K | |
| 08-Jun-21 6:03 PM View: | Kuhn Rebecca Chief Financial Officer | Neuropace Inc (NPCE) | 04-Jun-21 | Grant | 8,181 | -- | -- | 254% 3.23K to 11.41K |
